Oncologic outcomes of first-line bevacizumab/FOLFIRI in combination with Ginsenoside-modified nanostructured lipid carrier containing curcumin in unresectable metastatic colorectal cancer patients

Authors
Category Primary study
JournalEuropean Journal of Surgical Oncology
Year 2023
This article has no abstract
Epistemonikos ID: fc196bc19e9750256a1d03877ba43911256d6327
First added on: Feb 15, 2025